The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ziv-aflibercept in combination with FOLFIRI for 2nd-line treatment of patients with metastatic colorectal cancer: Interim safety data from the global aflibercept safety and quality-of-life program (ASQoP/AFEQT) in patients pretreated with bevacizumab.
 
Alberto F. Sobrero
Honoraria - Amgen; Bayer; Roche Pharma AG; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck; Roche Pharma AG; Sanofi
 
Roberto Bordonaro
Honoraria - Proacta; Sanofi
Consulting or Advisory Role - Proacta; Sanofi
Speakers' Bureau - Novartis; Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Katia Bencardino
No Relationships to Disclose
 
Filippo Pietrantonio
No Relationships to Disclose
 
Stefan Bauer
No Relationships to Disclose
 
Julien Taïeb
Honoraria - Sanofi
Consulting or Advisory Role - Sanofi
 
Pascale Garreau-Laporte
Employment - Sanofi
Leadership - Sanofi
 
Chiara Zilocchi
Employment - Sanofi
 
Emmanuelle Dochy
Employment - Sanofi
Leadership - Sanofi
 
Gérard Lledo
No Relationships to Disclose